SCHEMBL30796963

SCHEMBL30796963

COC(=O)c1cccc(N2[C@@H]3CC[C@H]2CN(c2cc(Cl)nnc2N)C3)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 2/20 0.46
▸ SMARCA4 P51532 2/20 0.46
▸ GAA P10253 1/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ GRM2 Q14416 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ HPGD P15428 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ESRRA P11474 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ LMNA P02545 1/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30796704 0.84 SMARCA2 (0.67) SMARCA2SMARCA4
SCHEMBL29943975 0.83 NPC1 (0.54) SMARCA2SMARCA4GAACNR1TP53
SCHEMBL23630487 0.83 NPC1 (0.54) SMARCA2SMARCA4GAACNR1TP53
SCHEMBL30796186 0.81 OPRM1 (0.52) SMARCA2SMARCA4MEN1KMT2AOPRM1
SCHEMBL23303143 0.81 OPRM1 (0.52) SMARCA2SMARCA4MEN1KMT2AOPRM1
SCHEMBL29910687 0.81 OPRM1 (0.52) SMARCA2SMARCA4MEN1KMT2AOPRM1
SCHEMBL23304144 0.80 SMARCA2 (0.43) SMARCA2SMARCA4CNR1OPRM1
SCHEMBL29910620 0.80 SMARCA2 (0.43) SMARCA2SMARCA4CNR1OPRM1
SCHEMBL23301218 0.79 KDM4E (0.43) SMARCA2SMARCA4MAPTALDH1A1KDM4E
SCHEMBL29942586 0.79 KDM4E (0.43) SMARCA2SMARCA4MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback